Improving the efficacy, safety, cost-effectiveness and acceptability of gonadotropin administration prior to in vitro fertilization - presented by William Keye, MD and A Markov Model of the Cost Effectiveness of Human-Derived FSH versus Recombinant FSH Using Comparative Clinical Trial Data  - presented by Hind Hatoum, PhD

Research Article: Subcutaneously administered Menopur®, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex® in subjects undergoing in vitro fertilization
- presented by William R. Keye, Bobby Webster, Richard Dickey, Stephen Somkuti, Jack Crain and M. Joseph Scobey